Delivery of RNA interference therapeutics using polycation-based nanoparticles

被引:170
作者
Howard, Kenneth Alan [1 ]
机构
[1] Univ Aarhus, Interdisciplinary Nanosci Ctr, Dept Mol Biol, DK-8000 Aarhus C, Denmark
关键词
Polycations; Nanoparticles; Polyplexes; RNA interference; siRNA; In vivo; Intravenous; Bioresponsive; Extracellular; Intracellular; POLYELECTROLYTE COMPLEX MICELLES; INHIBITS TUMOR-GROWTH; IN-VIVO; SIRNA DELIVERY; GENE DELIVERY; INTRACELLULAR TRAFFICKING; TRANSFECTION EFFICIENCY; NONHUMAN-PRIMATES; CATIONIC POLYMERS; SYSTEMIC DELIVERY;
D O I
10.1016/j.addr.2009.04.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
RNAi-based therapies are dependent on extracellular and intracellular delivery of RNA molecules for enabling target interaction. Polycation-based nanoparticles (or polyplexes) formed by self-assembly with RNA can be used to modulate pharmacokinetics and intracellular trafficking to improve the therapeutic efficacy of RNAi-based therapeutics. This review describes the application of polyplexes for extracellular and intracellular delivery of synthetic RNA molecules. Focus is given to routes of administration and silencing effects in animal disease models. The inclusion of functional components into the nanoparticle for controlling cellular trafficking and RNA release is discussed. This work highlights the versatile nature of polycation-based nanoparticles to fulfil the delivery requirements for RNA molecules with flexibility in design to evolve alongside an expanding repertoire of RNAi-based drugs. (C) 2009 Published by Elsevier B.V.
引用
收藏
页码:710 / 720
页数:11
相关论文
共 103 条
[1]   Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity [J].
Akhtar, Saghir ;
Benter, Ibrahim .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :164-182
[2]   Delivery of siRNA from lyophilized polymeric surfaces [J].
Andersen, Morten O. ;
Howard, Kenneth A. ;
Paludan, Soren R. ;
Besenbacher, Flemming ;
Kjems, Jorgen .
BIOMATERIALS, 2008, 29 (04) :506-512
[3]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[4]   Design and creation of new nanomaterials for therapeutic RNAi [J].
Baigude, Huricha ;
McCarroll, Joshua ;
Yang, Chao-shun ;
Swain, Pamela M. ;
Rana, Tariq M. .
ACS CHEMICAL BIOLOGY, 2007, 2 (04) :237-241
[5]   Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles [J].
Bartlett, Derek W. ;
Davis, Mark E. .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 99 (04) :975-985
[6]   Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles [J].
Bartlett, Derek W. ;
Davis, Mark E. .
BIOCONJUGATE CHEMISTRY, 2007, 18 (02) :456-468
[7]   Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging [J].
Bartlett, Derek W. ;
Su, Helen ;
Hildebrandt, Isabel J. ;
Weber, Wolfgang A. ;
Davis, Mark E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (39) :15549-15554
[8]   Progress towards in vivo use of siRNAs [J].
Behlke, MA .
MOLECULAR THERAPY, 2006, 13 (04) :644-670
[9]   DEMONSTRATION OF NUCLEAR COMPARTMENTALIZATION OF GLUTATHIONE IN HEPATOCYTES [J].
BELLOMO, G ;
VAIRETTI, M ;
STIVALA, L ;
MIRABELLI, F ;
RICHELMI, P ;
ORRENIUS, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4412-4416
[10]   Inhibition of respiratory viruses by nasally administered siRNA [J].
Bitko, V ;
Musiyenko, A ;
Shulyayeva, O ;
Barik, S .
NATURE MEDICINE, 2005, 11 (01) :50-55